Title : Safety and efficacy of ofatumumab in patients with fludarabine and alemtuzumab refractory chronic lymphocytic leukaemia.

Pub. Date : 2012 Aug

PMID : 23606931






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 The novel human IgG1 CD20 monoclonal antibody ofatumumab has shown significant activity in difficult to treat patients with chronic lymphocytic leukemia, namely those resistant or refractory to fludarabine and alemtuzumab and has now been licensed for this uncommon indication. fludarabine keratin 20 Homo sapiens